HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $551 | +6.4% | 7 | 0.0% | 0.00% | – |
| Q3 2022 | $518 | +13.6% | 7 | 0.0% | 0.00% | – |
| Q2 2022 | $456 | -51.9% | 7 | -53.3% | 0.00% | – |
| Q1 2022 | $948 | +155.5% | 15 | +114.3% | 0.00% | – |
| Q4 2021 | $371 | -97.2% | 7 | -93.9% | 0.00% | -100.0% |
| Q3 2018 | $13,177 | +5.0% | 115 | -17.9% | 0.01% | 0.0% |
| Q2 2018 | $12,555 | -79.1% | 140 | -82.9% | 0.01% | -79.1% |
| Q1 2018 | $60,064 | +26.0% | 821 | 0.0% | 0.04% | +22.9% |
| Q4 2017 | $47,684 | +29.4% | 821 | 0.0% | 0.04% | +25.0% |
| Q3 2017 | $36,838 | +13.6% | 821 | 0.0% | 0.03% | +7.7% |
| Q2 2017 | $32,421 | -2.7% | 821 | 0.0% | 0.03% | -7.1% |
| Q1 2017 | $33,308 | +0.9% | 821 | 0.0% | 0.03% | -6.7% |
| Q4 2016 | $33,004 | +11.0% | 821 | 0.0% | 0.03% | +11.1% |
| Q3 2016 | $29,728 | +24.9% | 821 | 0.0% | 0.03% | +22.7% |
| Q2 2016 | $23,801 | -44.2% | 821 | -32.6% | 0.02% | -45.0% |
| Q1 2016 | $42,641 | – | 1,219 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |